Skip to main content
Clinical Trials/KCT0000506
KCT0000506
Recruiting
未知

Electroacupuncture for Chemotherapy-induced Peripheral Neuropathy: A Randomized, Patient-Assessor Blinded, Controlled Pilot Clinical Trial

Korea Institute of Oriental Medicine0 sites40 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Diseases of the nervous system
Sponsor
Korea Institute of Oriental Medicine
Enrollment
40
Status
Recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Males and females aged 18 years and older
  • 2\. Patients who had received or were currently receiving neurotoxic chemotherapy with a diagnosis of cancer
  • 3\. Symptoms of peripheral neuropathy of duration \= 1 month attributed to chemotherapy, and a score \= 4 out of 10 on the NRS scale.
  • 4\. No use of medications to prevent or treat neuropathy within 2 weeks or stable use had been made in their medications to prevent or treat neuropathy within 2 months before screening.
  • 5\. ECOG PS of 0\-2
  • 6\. Life expectancy \= 6 months
  • 7\. Agreed with written informed consent

Exclusion Criteria

  • 1\. Pre\-existing or history of peripheral neuropathy due to any cause other than chemotherapy (diabetes, peripheral vascular disease, HIV, alcohol, toxin, hereditary, nerve compression injuries, etc.)
  • 2\.Known hypersensitivity reaction after acupuncture treatment or inability to cooperate with acupuncture procedure
  • 3\. Received acupuncture, moxibustion, cupping or herbal medicine for peripheral neuropathy last 4 weeks
  • 4\. Cardiovascular disorder (e.g. arrhythmia) or using pacemaker
  • 5\. Pregnant, expecting pregnant or nursing women
  • 6\. Those who are not willing to comply with this study protocol

Outcomes

Primary Outcomes

Not specified

Similar Trials